Skip to main content

Ocular Therapeutix, Inc

OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001393434

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Ocular Therapeutix, Inc changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of OCUL: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders2714262−5
Shares207.2M247.4K207.2M+242.3K (+0.1%)
Value$1.77B$2.10M$2.03B+$267.5M (+15.1%)

4 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Ocular Therapeutix, Inc at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to OCUL in Q2 2026
InstitutionSharesValue% of portfolio
Adage Capital Partners GP, L.L.C.1,550,000$15.2M0.02%
Trexquant Investment LP418,781$4.11M0.03%
OrbiMed Advisors LLC220,000$2.16M0.04%
CSM Advisors, LLC190,194$1.87M0.04%
Exome Asset Management LLC181,588$1.78M1.10%
Wealthspire Advisors, LLC162,960$1.60M0.01%
J. Goldman & Co LP101,760$999.3K0.04%
Jupiter Topco LLC68,500$672.3K0.00%
ExodusPoint Capital Management, LP51,730$508.0K0.00%
We Are One Seven, LLC45,989$451.6K0.01%
Engineers Gate Manager LP40,800$400.7K0.01%
Cowa, LLC38,181$374.9K0.09%
Campbell & CO Investment Adviser LLC31,135$305.7K0.02%
Gsa Capital Partners LLP26,707$262.0K0.02%
nVerses Capital, LLC26,117$256.5K0.39%
Jain Global LLC22,942$225.3K0.00%
Miracle Mile Advisors, LLC20,018$196.6K0.00%
Allstate Corp16,047$157.6K0.00%
Group One Trading, L.P.13,823$135.7K0.00%
Captrust Financial Advisors12,637$124.1K0.00%
Natixis11,880$116.7K0.00%
Trust Co of Vermont11,450$112.4K0.00%
Schonfeld Strategic Advisors LLC10,711$105.2K0.00%
Neuberger Berman Group LLC10,066$98.8K0.00%
Levin Capital Strategies, L.P.10,000$98.2K0.01%
Loring Wolcott & Coolidge Fiduciary Advisors LLP7,500$73.7K0.00%
Quarry LP3,238$31.8K0.01%
Nykredit A/S1,931$19.0K0.00%
Ameritas Advisory Services, LLC284$2.79K0.00%
Global Retirement Partners, LLC225$2.21K0.00%
Clearstead Advisors, LLC133$1.31K0.00%
Parallel Advisors, LLC82$8050.00%
Wealth Enhancement Trust Services, Inc.8$790.00%

Sold out (38)

Institutions that held Ocular Therapeutix, Inc at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (4)

Institutions that held Ocular Therapeutix, Inc at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OCUL in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
RoundAngle Advisors LLC166,484$1.41M
Janus Henderson Group PLC68,500$580.5K
CWM, LLC12,377$104.8K
Sunbelt Securities, Inc.15$127